Success of Inferior Alveolar Nerve Block in Women Taking Selective Serotonin Reuptake Inhibitors
Anesthetic Success of Inferior Alveolar Nerve Block for Mandibular Molars With Symptomatic Irreversible Pulpitis in Women Taking Selective Serotonin Reuptake Inhibitors
1 other identifier
observational
90
1 country
1
Brief Summary
To evaluate the success of inferior alveolar nerve block (IANB) for mandibular molars with irreversible pulpitis in women under treatment with selective serotonin reuptake inhibitors (SSRIs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 21, 2016
CompletedFirst Posted
Study publicly available on registry
August 31, 2016
CompletedFebruary 15, 2019
February 1, 2019
8 months
August 21, 2016
February 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the success rate of the IAN block
taking any type of SSRI for at least six weeks prior to the study
Interventions
Eligibility Criteria
Seventy adult women patients participated in this study and were assigned to either SSRIs users or SSRIs non-users groups. SSRIs users were 45 women who take SSRIs referred for endodontic treatment from a psychiatric clinic to the clinic of the endodontic department of Isfahan University of Medical Sciences. SSRIs non-users were 45 women who did not take SSRIs referred for endodontic treatment to the same dental clinic.
You may qualify if:
- vital mandibular molar tooth
- diagnosis of symptomatic irreversible pulpitis
You may not qualify if:
- younger than 18 years old
- history of significant medical conditions
- allergies to local anesthetics or sulfites
- pregnancy
- active sites of pathosis in area of injection
- inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Dentistry, Isfahan University of Medical Sciences
Isfahan, 81747673461, Iran
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Abbasali khademi
Isfahan University of Medical Sciences
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Endodontics, School of Dentistry, Isfahan University of Medical Sciences
Study Record Dates
First Submitted
August 21, 2016
First Posted
August 31, 2016
Study Start
June 1, 2015
Primary Completion
February 1, 2016
Study Completion
March 1, 2016
Last Updated
February 15, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share